Number of the records: 1  

SPINK9 Stimulates Metalloprotease/EGFR-Dependent Keratinocyte Migration via Purinergic Receptor Activation

  1. 1.
    SYSNO ASEP0434707
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSPINK9 Stimulates Metalloprotease/EGFR-Dependent Keratinocyte Migration via Purinergic Receptor Activation
    Author(s) Sperrhacke, M. (DE)
    Fischer, J. (DE)
    Wu, Z.H. (DE)
    Klunder, S. (DE)
    Sedláček, Radislav (UMG-J) RID
    Schroeder, J.M. (DE)
    Meyer-Hoffert, U. (DE)
    Reiss, K. (DE)
    Source TitleJournal of Investigative Dermatology - ISSN 0022-202X
    Roč. 134, č. 6 (2014), s. 1645-1654
    Number of pages10 s.
    Languageeng - English
    CountryUS - United States
    KeywordsSPINK ; ADAM ; keratinocyte
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsGAP303/10/2044 GA ČR - Czech Science Foundation (CSF)
    Institutional supportUMG-J - RVO:68378050
    UT WOS000336193700023
    DOI10.1038/jid.2014.23
    AnnotationSerine protease inhibitors of the Kazal-type 9 (SPINK9) is a keratinocyte-derived cationic peptide that is found most abundantly in the upper layers of the palmar plantar epidermis. In vitro, the peptide displays the capacity to inhibit specifically kallikrein-related peptidase 5 (KLK5). Here, we report that cells expressing SPINK9 secrete the peptide constitutively. Recombinant SPINK9 (rSPINK9) provoked transactivation of the EGFR in human keratinocytes, resulting in efficient downstream triggering of cell migration. Transactivation occurred via functional upregulation of a disintegrin and metalloproteases (ADAMs), as evidenced by suppression with a metalloproteinase inhibitor and an EGFR-blocking antibody. SPINK9 preparations isolated from human skin also displayed EGFR-transactivating capacity. The classical purinergic receptor antagonists oxidized ATP and pyridoxalphosphate-6-azophenyl-2',4',-disulfonic acid effectively suppressed EGFR transactivation by rSPINK9, indicating that in analogy to what has recently been reported for the cationic antimicrobial peptides cathelicidin LL-37 and bee venom melittin, purinergic receptors have an essential bridging role in promoting the upregulation of ADAM function by the cationic peptide. SPINK9 could represent an example of how a cationic peptide may subserve multiple and interrelated functions that contribute to the maintenance of the physical and immunological barrier of the skin.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2015
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.